Within the glioblastoma TME, GAMs and tumour cells have been identified as the main sources of CCL2, though evidence suggests GAM-secreted CCL2 has a more significant impact, possibly due to higher levels being produced [67,68]. This evidence concerns the gene CCL2 and glioblastoma.